Cytek Biosciences (CTKB) Common Equity (2020 - 2026)
Cytek Biosciences' Common Equity came in at $321.95 million for Q2 2026, down 14.7% from $377.56 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Cytek Biosciences (CTKB) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Cytek Biosciences' Common Equity was $341.74 million, down 13.6% from FY2024.
- Going back by year, Common Equity was $395.74 million in FY2024 (+0.7%), $393.06 million in FY2023 (-7.6%), $425.55 million in FY2022 (+5.0%) and $405.39 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q2 2021.
- Year-over-year, Common Equity has declined for six consecutive quarters, with an average decline of 7.1% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2022 (growth of 5.0%), and the weakest in Q2 2026 (a decline of 14.7%).
- Business Quant data shows CTKB's Common Equity at $327.64 million (Q1 2026), $341.74 million (Q4 2025) and $378.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Cytek Biosciences | 748.70 Mn | 424.97 Mn | 28.34 Mn | 321.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 321.95 Mn |
| Mar 31, 2026 | 327.64 Mn |
| Dec 31, 2025 | 341.74 Mn |
| Sep 30, 2025 | 378.57 Mn |
| Jun 30, 2025 | 377.56 Mn |
| Mar 31, 2025 | 379.62 Mn |
| Dec 31, 2024 | 395.74 Mn |
| Sep 30, 2024 | 385.46 Mn |
| Jun 30, 2024 | 389.12 Mn |
| Mar 31, 2024 | 392.61 Mn |
| Dec 31, 2023 | 393.06 Mn |
| Sep 30, 2023 | 415.52 Mn |
| Jun 30, 2023 | 424.18 Mn |
| Mar 31, 2023 | 423.46 Mn |
| Dec 31, 2022 | 425.55 Mn |
| Sep 30, 2022 | 416.51 Mn |
| Jun 30, 2022 | 411.13 Mn |
| Mar 31, 2022 | 407.44 Mn |
| Dec 31, 2021 | 405.39 Mn |
| Sep 30, 2021 | 403.20 Mn |
API Access
Cytek Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CTKB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CTKB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CTKB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();